Details for New Drug Application (NDA): 022460

✉ Email this page to a colleague

NDA 022460 describes JALYN, which is a drug marketed by Waylis Therap and is included in one NDA. It is available from one supplier. Additional details are available on the JALYN profile page.

The generic ingredient in JALYN is dutasteride; tamsulosin hydrochloride. There are eighteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the dutasteride; tamsulosin hydrochloride profile page.

Summary for 022460

Tradename:	JALYN
Applicant:	Waylis Therap
Ingredient:	dutasteride; tamsulosin hydrochloride
Patents:	0

Pharmacology for NDA: 022460

Mechanism of Action	5-alpha Reductase Inhibitors Adrenergic alpha-Antagonists

Suppliers and Packaging for NDA: 022460

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
JALYN	dutasteride; tamsulosin hydrochloride	CAPSULE;ORAL	022460	NDA	Waylis Therapeutics	80725-809	80725-809-13	30 CAPSULE in 1 BOTTLE, PLASTIC (80725-809-13)
JALYN	dutasteride; tamsulosin hydrochloride	CAPSULE;ORAL	022460	NDA	Waylis Therapeutics	80725-809	80725-809-59	90 CAPSULE in 1 BOTTLE, PLASTIC (80725-809-59)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	CAPSULE;ORAL			Strength	0.5MG;0.4MG
Approval Date:	Jun 14, 2010	TE:	AB	RLD:	Yes

Expired US Patents for NDA 022460

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Waylis Therap	JALYN	dutasteride; tamsulosin hydrochloride	CAPSULE;ORAL	022460-001	Jun 14, 2010	5,565,467	⤷ Subscribe
Waylis Therap	JALYN	dutasteride; tamsulosin hydrochloride	CAPSULE;ORAL	022460-001	Jun 14, 2010	5,998,427	⤷ Subscribe
Waylis Therap	JALYN	dutasteride; tamsulosin hydrochloride	CAPSULE;ORAL	022460-001	Jun 14, 2010	5,846,976	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.